Search

Background to the Debate: In 2004, the United States Food and Drug Administration approved a radiofrequency identification (RFID) device that is implanted under the skin of the upper arm of patients and that stores the patient's medical identifier. When a scanner is passed over the device, the identifier is displayed on the screen of an RFID reader. An authorized health professional can then use the identifier to access the patient's clinical information, which is stored in a separate, secure database. Such RFID devices may have many medical benefits--such as expediting identification of patients and retrieval of their medical records. But critics of the technology have raised several concerns, including the risk of the patient's identifying information being used for nonmedical purposes.

Objectives: Numerous studies have used maternally linked birth records to investigate perinatal outcomes, maternal behaviors, and the quality of vital records birth data. Little attention has been given to assessing errors in the linkages and to understanding how such errors affect estimates derived from the linked data. The author developed a framework for conceptualizing maternal linkage error and measures for quantifying it, and examined the behavior of the new measures in a maternally linked file., Methods: Linkage errors were conceptualized as misclassification, with the classes being the maternal sets (records classified as representing different births to the same woman). The true linkage proportion, analogous to sensitivity, was used to capture the degree to which all of a woman's births were assigned to a single maternal set; the false linkage proportion, analogous to specificity, was used to capture the degree to which the assigned maternal sets combined births from different women. The behavior of the two proportions was examined by introducing increasing degrees of linkage error into a maternally linked file., Results: Both measures indicated greater misclassification with increasing simulated linkage errors., Conclusions: The new measures may be a useful tool for assessing the quality of maternally linked data, as well as other types of linked records where the linkages are within a single file. This is a necessary step towards developing methods for addressing misclassification bias in studies of maternally linked records through sensitivity analysis, adjustment, and other means.

Background: Multiplication of data sources within heterogeneous healthcare information systems always results in redundant information, split among multiple databases. Our objective is to detect exact and approximate duplicates within identity records, in order to attain a better quality of information and to permit cross-linkage among stand-alone and clustered databases. Furthermore, we need to assist human decision making, by computing a value reflecting identity proximity., Methods: The proposed method is in three steps. The first step is to standardise and to index elementary identity fields, using blocking variables, in order to speed up information analysis. The second is to match similar pair records, relying on a global similarity value taken from the Porter-Jaro-Winkler algorithm. And the third is to create clusters of coherent related records, using graph drawing, agglomerative clustering methods and partitioning methods., Results: The batch analysis of 300,000 "supposedly" distinct identities isolates 240,000 true unique records, 24,000 duplicates (clusters composed of 2 records) and 3,000 clusters whose size is greater than or equal to 3 records., Conclusion: Duplicate-free databases, used in conjunction with relevant indexes and similarity values, allow immediate (i.e. real-time) proximity detection when inserting a new identity.

The Food and Drug Administration (FDA) is classifying the implantable radiofrequency transponder system for patient identification and health information into class II (special controls). The special control that will apply to the device is the guidance document entitled "Class II Special Controls Guidance Document: Implantable Radiofrequency Transponder System for Patient Identification and Health Information." The agency is classifying the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device. Elsewhere in this issue of the Federal Register, FDA is publishing a notice of availability of a guidance document that is the special control for this device.

Accurate health information is a key component in the development of health improvement strategies. This paper provides a discussion of the challenges in improving hospital information systems in relation to indigenous patients. Based on interviews with both staff and patients of a major city hospital complex, a picture emerges of the need for bottom-up approaches to understanding perceptions of identity. Indigenous patients were found to be generally comfortable about identifying themselves on hospital records (if asked), but were often not clear why such questions were asked. On the other hand hospital staff were often uncomfortable about asking and were equally not always clear why such information was needed. Issues of accurate hospital record administration are discussed in relation to the attitudes and perceptions of both staff and patients.

Learn how three large, affiliated healthcare facilities in Atlanta accepted the challenge of developing and implementing an electronic medical record system. The main obstacle--dealing with multiple patient identifiers--is outlined and practical and proven solutions are detailed.

The literature concerning the diffusion of innovations reveals that it is not surprising that a promising technology is confronting obstacles in its development and implementation. Alternative technologies also often appear that address the same or similar problems. Better information enables physicians to provide medical care that is less expensive and less error prone. The prescription of medications is reduced in number and cost when the prescribing physician knows the current and previous medications of the patient. The ordering of clinical tests is reduced in number and cost, and the ordering of timely retesting is more likely when physicians have before them information about previous testing of their patient. The challenge is in how the portability of the patient card and its ability to be self-contained can enhance medical practice.